Serum leptin concentrations during the menstrual cycle in normal-weight women: effects of an oral triphasic estrogen-progestin medication

Department of Endocrinology, Dipartimento di Scienze Endocrinologiche e Metaboliche (DiSEM), University of Genova, Viale Benedetto XV-6, 16132 Genova, Italy.

OBJECTIVE: To investigate in normal-weight premenopausal women the relationship between circulating leptin and serum gonadotropins and gonadal steroids, during both spontaneous and pharmacologically induced menstrual cycles. DESIGN: Clinical longitudinal study. METHODS: Two groups of age-matched, normal-weight premenopausal volunteer women (groups I and II) were enrolled in this study. Women in group I were free of any hormonal treatment, while women in group II were taking a triphasic estrogen--progestin contraceptive preparation. Blood samples were collected daily in both groups after an overnight fast throughout a complete menstrual cycle. RESULTS: In the spontaneously cycling women, serum leptin concentration positively correlated with estradiol (P<0.03) and progesterone (P<0. 05) and was higher in the luteal than in the follicular phase (P<0. 05). However, a significant (P<0.03) short-lasting increase in circulating leptin was present in the late follicular phase of all subjects. In the women using hormonal contraception serum leptin remained unchanged throughout the cycle, along with constantly low values of circulating luteinizing hormone and follicle-stimulating hormone. CONCLUSIONS: In normal-weight premenopausal women serum leptin concentrations differ during the menstrual cycle in line with changes in gonadotropin and gonadal steroid concentrations, increasing in the luteal phase of the cycle after a peri-ovulatory peak. These findings suggest a permissive role for leptin with regard to the functioning of the corpus luteum.

This article has been cited by other articles:

				L. Vona-Davis and D. P Rose Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression Endocr. Relat. Cancer, June 1, 2007; 14(2): 189 - 206. [Abstract] [Full Text] [PDF]

				M. C. Henson and V. D. Castracane Leptin in Pregnancy: An Update Biol Reprod, February 1, 2006; 74(2): 218 - 229. [Abstract] [Full Text] [PDF]

				R. Leminen, T. Raivio, S. Ranta, J. Oehler, H. von Hertzen, O. A Janne, and O. Heikinheimo Late follicular phase administration of mifepristone suppresses circulating leptin and FSH - mechanism(s) of action in emergency contraception? Eur. J. Endocrinol., March 1, 2005; 152(3): 411 - 418. [Abstract] [Full Text] [PDF]

				T. Saaresranta, K. Irjala, and O. Polo Effect of medroxyprogesterone on arterial blood gases, leptin and neuropeptide Y in postmenopausal females Eur. Respir. J., December 1, 2002; 20(6): 1413 - 1418. [Abstract] [Full Text] [PDF]

				I. E. Messinis, I. Papageorgiou, S. Milingos, E. Asprodini, G. Kollios, and K. Seferiadis Oestradiol plus progesterone treatment increases serum leptin concentrations in normal women Hum. Reprod., September 1, 2001; 16(9): 1827 - 1832. [Abstract] [Full Text] [PDF]

				R. H. Lane, D. E. Kelley, E. M. Gruetzmacher, and S. U. Devaskar Uteroplacental insufficiency alters hepatic fatty acid-metabolizing enzymes in juvenile and adult rats Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2001; 280(1): R183 - R190. [Abstract] [Full Text] [PDF]

				I.E. Messinis, I. Kariotis, S. Milingos, G. Kollios, and K. Seferiadis Treatment of normal women with oestradiol plus progesterone prevents the decrease of leptin concentrations induced by ovariectomy Hum. Reprod., November 1, 2000; 15(11): 2383 - 2387. [Abstract] [Full Text] [PDF]

				M. C. Henson and V. D. Castracane Leptin in Pregnancy Biol Reprod, November 1, 2000; 63(5): 1219 - 1228. [Abstract] [Full Text]